NASDAQ : AXGN
Axogen, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 49.85 USD (Nov 2, 2026, 4:00 PM EST) · Market cap 2.98B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.98B |
| Enterprise Value | 2.65B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 59.73M |
| Shares Outstanding | 59.73M |
| Shares Change (YoY) | +12.44% |
| Shares Change (QoQ) | +15.35% |
| Owned by Insiders (%) | 1.91% |
| Owned by Institutions (%) | 90.41% |
| Float | 54.61M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.19 |
| Forward PS | 8.48 |
| PB Ratio | 5.94 |
| P/TBV Ratio | 6.12 |
| P/FCF Ratio | 135.51 |
| P/OCF Ratio | 105.31 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 9.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 120.60 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 12.02 |
| Quick Ratio | 10.48 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.88 |
| Interest Coverage | -5.72 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -10.35% |
| Return on Assets (ROA) | -2.25% |
| Return on Invested Capital (ROIC) | -2.44% |
| Return on Capital Employed (ROCE) | -2.69% |
| Weighted Average Cost of Capital (WACC) | 10.66% |
| Revenue Per Employee | $429,141 |
| Profits Per Employee | -$51,322 |
| Employee Count | 622 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 1.54 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +124.26% |
| 50-Day Moving Average | 42.84 |
| 200-Day Moving Average | 39.66 |
| Relative Strength Index (RSI) | 74.59 |
| Average Volume (20 Days) | 1,856,347 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.12M |
| Short Previous Month | 4.70M |
| Short % of Shares Out | 8.58% |
| Short % of Float | 9.38% |
| Short Ratio (days to cover) | 3.57 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 266.93M |
| Gross Profit | 198.00M |
| Operating Income | -13.81M |
| Pretax Income | -31.92M |
| Net Income | -31.92M |
| EBITDA | -6.96M |
| EBIT | -13.81M |
| Loss Per Share | -$0.62 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 348.07M |
| Total Debt | 19.47M |
| Net Cash | 328.60M |
| Net Cash Per Share | $5.50 |
| Equity (Book Value) | 496.10M |
| Book Value Per Share | 8.31 |
| Working Capital | 401.64M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 28.36M |
| Capital Expenditures | -6.32M |
| Depreciation & Amortization | 6.84M |
| Net Borrowing | -48.62M |
| Free Cash Flow | 22.04M |
| FCF Per Share | $0.37 |
Margins
| Measure | Value |
|---|
| Gross Margin | 74.18% |
| Operating Margin | -5.17% |
| Pretax Margin | -11.96% |
| Profit Margin | -11.96% |
| EBITDA Margin | -2.61% |
| EBIT Margin | -5.17% |
| FCF Margin | 8.26% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -12.44% |
| Shareholder Yield | -12.44% |
| Earnings Yield | -1.24% |
| FCF Yield | 0.74% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $59.09 |
| Price Target Difference | 18.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 25.83% |
| EPS Growth Forecast (3Y) | 50.93% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 20.77 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |